Biomimetic nanomedicines for precise atherosclerosis theranostics

Biomimetic nanomedicines for precise atherosclerosis theranostics

Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-ba...

Full description

Bibliographic Details
Main Authors: Ying Tao, Xinmiao Lan, Yang Zhang, Chenxing Fu, Lu Liu, Feng Cao, Weisheng Guo
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Nanotheranostics
Atherosclerosis
Biomimetic nanomedicines
Drug delivery
Passive targeting
Active targeting
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383522004816

Internet

http://www.sciencedirect.com/science/article/pii/S2211383522004816

Similar Items